Clinical Trial Update: CemiplimAb Survivorship Epidemiology

View source ↗

Summary

Completed clinical trial studying survivorship epidemiology for cemiplimab in skin cancers, including cutaneous squamous cell carcinoma and basal cell carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Libtayo (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma | Status: COMPLETED